What is the ticker symbol for Talphera?

Talphera trades under the ticker TLPH on NASDAQ.

What sector does Talphera operate in?

Talphera is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze TLPH in a portfolio?

PortView shows TLPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Talphera (TLPH) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$1.19+0.42%

1-year price historyRange $0.52 – $1.47

52-week range$1.19

$0.50$1.57

What Talphera does

Talphera, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapeutic products intended for use in carefully monitored medical environments. Their lead experimental candidate is Niyad, a lyophilized (freeze-dried) formulation of nafamostat. This anticoagulant is currently being assessed under an investigational device exemption for its application in extracorporeal circuits. The company's development pipeline also features LTX-608, a potential anti-inflammatory and antiviral agent being explored for the treatment of numerous conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis. Furthermore, Talphera is advancing Fedsyra, a pre-filled syringe containing ephedrine, and PFS-02, a pre-filled syringe containing phenylephrine. Established in 2005, the company was previously known as AcelRx Pharmaceuticals, Inc. It adopted the name Talphera, Inc. in January 2024 and maintains its corporate headquarters in San Mateo, California.

Key metrics

Market cap

$61.50M

P/E (TTM)

-3.82

EPS (TTM)

$-0.31

Beta

0.70

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.26

200-day avg

$1.02

52-week high

$1.57

52-week low

$0.50

CEO

Vincent J. Angotti

ETFs linked to TLPH

Broad-market and Healthcare sector ETFs an investor holding Talphera is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how TLPH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TLPH in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Talphera?: Talphera trades under the ticker TLPH on NASDAQ.
Which exchange is TLPH listed on?: TLPH is listed on NASDAQ.
What sector does Talphera operate in?: Talphera is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze TLPH in a portfolio?: PortView shows TLPH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.